Can untrained dogs smell cancer? Find Out Here

Will Doctors Use Eventually Dogs to Detect Cancer?

It is very unlikely that a dog will be used as the only way to detect cancer, especially with all of the modern technology that exists today. It has not been fully determined whether dogs can be reliably trained to smell cancer at this point in time. At least not on a consistent basis. Proving that this method of cancer detection is accurate enough to use very well could be many years away, if ever. Even if we do reach the point where a dog can accurately detect cancer, it would be very difficult to train a dog to communicate what they have smelled without further testing being administered.

The Science Behind a Dog’s Sniffer

In her book Nose of a Dog, research scientist Alexandra Horowitz notes that “most of what the dog sees and knows comes through his nose.” Depending on the breed, a dog’s nose has around 125 million to 300 million scent glands, while a human’s nose has around five million scent glands. That means that a dog’s sense of smell is around 1,000 to 100,000 times more sensitive than a human’s.

Research indicates that dogs are capable of detecting tiny traces of odors created by different diseases. How tiny? Around one part per trillion, or the equivalent of one teaspoon of sugar in two Olympic-sized swimming pools.

This, of course, is something that we don’t actually know. What we do know is that dogs are capable of smelling these smells, however infinitesimal they may be. That means that untrained dogs can pick up on the smell of cancer and might start behaving differently, although they could just behave the very same.

According to the National Institutes of Health, human beings can identify more than 1 trillion smells. That’s a number so high that it outstretches the number of words the average person knows by about 20,000,000 times.

The average American knows around 50,000 words. The point is, our noses are capable of pretty amazing things.

Not if you asked a dog, though. Dogs smell roughly 100,000 times better than we do. This allows them to pick up on scents that are so minuscule, so faint, and so refined that the canine nose might be a reasonable alternative to highly advanced detectors for medical illnesses.

Dogs Can Smell Cancer | Secret Life of Dogs | BBC Earth

[Updated below with information about a new UK clinical trial to see if dogs can aid in the detection of prostate, kidney and bladder tumours, 10/08/15 KA]

The idea that dogs can detect cancer has been around for a while, perpetuated on the internet (for example here) and in a BBC4 documentary first broadcast in 2006.

There are many anecdotes of family pets persistently sniffing or worrying at a certain area on their owner, which subsequently turns out to harbour a tumour.

As a result, we receive numerous enquiries asking whether Cancer Research UK is investigating this phenomenon.

But is there any scientific basis behind the idea? And if there is, are dogs really a practical solution for cancer screening?

Picking up the scent All smells – from the pleasant aroma of freshly cut grass to the whiff of Stinking Bishop – are due to molecules diffusing in the air, given off by whatever is causing the pong.

These so-called volatile molecules are detected by scent (olfactory) receptors in the noses of humans and animals, sending signals to the brain which then interprets the smell. Dogs have an astounding sense of smell, because their noses are packed with many times more scent receptors than humans have.

We know that some tumours produce unusual volatile molecules (such as lung cancer, breast cancer, and melanoma) which are presumably being picked up by the dogs in the stories mentioned above. But does this mean that we should have “cancer sniffer dogs” in every GP surgery?

Putting it to the test A small number of studies have set out to directly investigate whether dogs can detect cancer under controlled conditions, and one of the key pieces of research is a paper by Carolyn Willis and her colleagues in the UK.

Her team trained six dogs to tell the difference between urine samples from bladder cancer patients and samples from healthy people. When the dogs were presented with new samples – six from healthy people and one from a cancer patient – the scientists found they could pick out urine samples from people with cancer 41 per cent of the time (22 out of 54 tests). If they were correct only by chance, we would expect the dogs to pick the right sample only 14 per cent of the time (i.e. one in seven).

Michael McCulloch in the US has also looked into the phenomenon. His team trained 5 ordinary dogs using breath samples from lung and breast cancer patients, as well as 83 samples from healthy people. Then they tested the dogs with new samples from patients or healthy people that they hadn’t previously sniffed.

The test was double-blinded, meaning that neither the dog handlers nor the researchers watching them knew which samples were which. The results were promising – with only a few weeks training, the team found that the dogs could correctly spot the samples from cancer patients with high levels of accuracy.

But another study by Robert Gordon and his colleagues in California showed less impressive results. In a study involving six dogs, only two performed better at detecting urine samples from patients with breast cancer than you might expect by chance. And in a test of four dogs, only two could pick out urine samples from prostate cancer patients at a rate better than predicted by chance.

In August 2015, the charity Medical Detection Dogs announced that they are launching a large-scale clinical study in the UK, using nine dogs to test samples from 3,000 patients to check for prostate, bladder and kidney cancer. We provided this comment to the media about the study, which was used in part in some of the coverage:

Dr Kat Arney, Cancer Research UK’s science information manager, said: “Any test for cancer must be shown to be reliable, specific and practical, and large-scale clinical trials are an essential part of this process. It will be interesting to see whether this new trial shows that dogs can identify prostate cancer better than current tests, but it’s unlikely that canine cancer screening would be practical in the clinic on a wider scale. In the long term it would be useful to discover the identities of the molecules the dogs are sniffing, which could lead to more accurate lab tests to diagnose cancer.” [Updated 10/08/15 KA]

Practical problems It’s certainly a nice idea – man’s best friend sniffing out tumours. But although these small research studies show that dogs could have the potential to pick up cancer, their accuracy is questionable.

This is problematic because in the case of tests for cancer, it’s important to have a test that is as reliable and accurate as possible – although, of course, no test is ever 100 per cent infallible. This cuts down on the chance that cancers will be missed (false negatives), or that a diagnosis of cancer will be wrongly made (false positives).

Also, it’s simply not realistic to transfer this to a clinical setting. For a start, there are the practical considerations. Dogs would need to be trained, housed and fed, and would not be able to work for more than a few hours at a time for the sake of their welfare.

More importantly, it’s still not clear from the research that the dogs are picking up specific molecules originating from a tumour, or are just picking up molecules associated with more general illness. And there’s also the chance that they may be confused by other scent molecules on the breath or in urine, such as garlic, asparagus, tobacco, alcohol or other pungent foods.

Dogs are also – obviously – unable to tell doctors exactly which molecules are faulty in an individual’s cancer – information that can be obtained using molecular diagnostic techniques. This is important because such information is increasingly being used to tailor treatment to an individual’s cancer.

But although Fido won’t be wearing a canine labcoat any time soon, there’s a lot of research going on into detecting the scent of cancer.

Introducing the electronic nose Although they don’t have furry coats, there are “electronic noses” that can pick up the volatile molecules produced by cancer cells with greater accuracy than a real life cold, wet one. This kind of technology is being tested in a range of cancers, including breast and lung.

It’s still early days for electronic noses, and we need to see a lot more research to make sure the machines are accurate and reliable at detecting cancer. But once the technology has advanced further, it’s likely that they will have wide applications for detecting many different types of cancer. And they won’t need feeding or walking either.

C DENG (2004). Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography?mass spectrometry Journal of Chromatography B, 808 (2), 269-277 DOI: 10.1016/j.jchromb.2004.05.015

Michael Phillips et al (2006). Prediction of breast cancer using volatile biomarkers in the breath Breast Cancer Research and Treatment, 99 (1), 19-21 DOI: 10.1007/s10549-006-9176-1

A. D’Amico et al (2008). Identification of melanoma with a gas sensor array Skin Research and Technology, 14 (2), 226-236 DOI: 10.1111/j.1600-0846.2007.00284.x

C. M Willis (2004). Olfactory detection of human bladder cancer by dogs: proof of principle study BMJ, 329 (7468) DOI: 10.1136/bmj.329.7468.712

M. McCulloch (2006). Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers Integrative Cancer Therapies, 5 (1), 30-39 DOI: 10.1177/1534735405285096

Robert T. Gordon et al (2008). The Use of Canines in the Detection of Human Cancers The Journal of Alternative and Complementary Medicine, 14 (1), 61-67 DOI: 10.1089/acm.2006.6408

K GENDRON et al (2007). In vitro discrimination of tumor cell lines with an electronic nose Otolaryngology – Head and Neck Surgery, 137 (2), 269-273 DOI: 10.1016/j.otohns.2007.02.005

H CHAN, C LEWIS, P THOMAS (2009). Exhaled breath analysis: Novel approach for early detection of lung cancer Lung Cancer, 63 (2), 164-168 DOI: 10.1016/j.lungcan.2008.05.020